Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion type Assertion NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_head.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion description "[RASSF1A promoter hypermethylation was detected in 100% of SCLC, in 63% of NSCLC, in 64% of breast cancer lines, in 30% of primary NSCLCs, and in 49% of primary breast tumors but in none of the nonmalignant lung tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion evidence source_evidence_literature NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion SIO_000772 11333291 NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion wasDerivedFrom befree-2016 NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.
- NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_assertion wasGeneratedBy ECO_0000203 NP316688.RA3eLCDgPyBK8U4MZMXAapvx0qgvmrubFGav1ZRrxGP6I130_provenance.